drugset / Trial / NCT01466478

An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris

NCT01466478

Phase 1 Completed 24 enrolled LEO Pharma
NaSingle-groupSingle-blindOther

Summary

The purpose of the study is to compare the 3 ointment formulations containing LEO 29102 plus calcipotriol and Daivonex® ointment and Diprosone® ointment and to compare LEO 29102 plus calcipotriol to LEO 29102 alone and to calcipotriol alone in the same ointment vehicle, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.

Timeline

Start
2011-11
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule 50 unknown Topical
Subject Calcipotriol Small molecule Topical
Subject LEO 29102 Unknown 2.5 unknown Topical
Subject betamethasone dipropionate Small molecule Topical

Indications